Skip to content

Physical Activity in Insurance Medicine: Effects on Patients With Psychiatric Disorders

Physical Activity in Insurance Medicine: Effects on Psycho(-Physio-)Logical Functions, Capacity / Participation Skills, and the Ability to Work in Psychiatric Disorders

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01928264
Acronym
PhysActIV
Enrollment
13
Registered
2013-08-23
Start date
2013-08-31
Completion date
2014-04-30
Last updated
2015-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety Disorder, Depressive Disorder, Personality Disorder, Somatoform Disorder

Keywords

Mental disorders, Physical activity, Disability pension, Disability pension due to mental illness, Ability to work, Mental toughness

Brief summary

We will conduct a randomized control trial to investigate whether and to what extent regular and guided group physical activity over 12 weeks (2 sessions à 1 hour/week) improves physical fitness and (physio-)psychological functions (like subjective sleep, mental toughness, perceived stress, self-efficacy, etc.), as well as participation skills and the ability to work, in claimants for a disability pension due to psychiatric disorders, whose ability to work had recently been assessed by means of a psychiatric expert opinion. The control group is designed very similar and implies predominantly sedentary leisure time group activities (e.g. playing board games, doing handicrafts). Measures will be performed at baseline, post-test, and at follow ups three and twelve months after post-test, some variables will additionally be assessed 4-weekly during the intervention. We expect that intervention group participants will report and show, respectively, more improved physical fitness, (physio-)psychological functioning and participations skills, as well as increased ability to work, compared to the control group.

Interventions

BEHAVIORALPhysical activity

Sponsors

Psychiatric Hospital of the University of Basel
CollaboratorOTHER
Institute for Exercise and Health Sciences, University of Basle, Switzerland
CollaboratorOTHER
University Hospital, Basel, Switzerland
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

* Claimants for a disability pension due to a mental disorder, whose ability to work has been recently assessed by means of a psychiatric expert opinion * Both genders * 18-55 years old * Clinical diagnosis of depressive disorder, somatoform disorder, anxiety disorder, personality disorder * Sufficient competence in understanding, speaking and reading German * Sufficient cognitive, emotional and social level of functioning to be able to participate in a group * Physical Activity Readiness Questionnaire without evidence for reduction * or: Physical activity readiness certificated by the general practitioner * Informed consent

Exclusion criteria

* Comorbidity with a somatic disorder that limits the ability for physical exercises * Pregnancy * Ongoing disturbance of the study

Design outcomes

Primary

MeasureTime frame
Change in the ability to work (h/d / %)baseline and 15 months

Secondary

MeasureTime frame
Change in psychological functioning (sum scores)baseline and 15 months
Change in Leisure-time physical activity (sum score)baseline and 15 months
Change in self-efficacy (sum score)baseline and 15 months
Change in the ability to work (h/d / %)baseline and 6 months
Change in participation skills (sum score)baseline and 15 months
Change in subjective sleep quality (sum score)baseline and 15 months
Change in subjectively perceived stress (sum score)baseline and 15 months
Change in Clinical Global Impression (sum score)baseline and 15 months

Other

MeasureTime frame
Change in perceived fitness (sum score)baseline and 15 months
Change in physical fitness (VO2max = ml/kg/min)baseline and 15 months

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026